Hemispherx Biopharma Files $150M Mixed-Securities Shelf >HEB
31 minutes ago - Dow Jones News
Related Companies
<TABLE class=dataTable cellSpacing=0 cellPadding=0 width="100%"><THEAD><TR><TD>Symbol</TD><TD align=right>Last</TD><TD align=right>%Chg</TD></TR></THEAD><TBODY><TR><TD>
HEB</TD><TD align=right>2.84</TD><TD align=right>-6.89%</TD></TR></TBODY></TABLE>As of 4:00 PM ET 6/9/09
<STORY>
DOW JONES NEWSWIRES
Hemispherx Biopharma Inc. (
HEB) on Tuesday registered with the Securities and Exchange Commission to sell from time to time up to $150 million of common stock, preferred stock, debt securities and warrants.
The specialty pharmaceutical company said it intends to use the net proceeds for general corporate purposes.
No underwriters were listed in the filing.
Shares of the company closed Tuesday at $2.84 each, down 21 cents, or 6.89%.
-Denise Jia, Dow Jones Newswires; 202-862-1359;
denise.jia@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary:
http://www.djnewsplus.com/nae/al?rnd=O38H8BbZcG2bRFg5G6F1NQ==. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
06-09-09 1715ET
Copyright (c) 2009 Dow Jones & Company, Inc.</STORY>